Modulation of MMP-2 and MMP-9 by cytokines, mitogens and inhibitors in lung cancer and malignant mesothelioma cell lines

Oncology Reports

Volumn 22, Issue 6, 2009, Pages 1283-1291

  Roomi, M Waheed ^a   Monterrey, Julio C ^a   Kalinovsky, Tatiana ^a   Niedzwiecki, Aleksandra ^a   Rath, Matthias ^a  

^a Dr Rath Research Institute   (United States)

Author keywords

Cytokines; Inhibitors; Lung cancer; Mesothelioma; Mitogens; MMP 2; MMP 9

Indexed keywords

CYTOKINE; DACTINOMYCIN; DOXYCYCLINE; EPICATECHIN GALLATE; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; MITOGENIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; DENSITOMETRY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPATHOGENESIS; LUNG CANCER; MALIGNANT MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ZYMOGRAPHY;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CULTURE MEDIA; CYTOKINES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIPOPOLYSACCHARIDES; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MESOTHELIOMA; NEOPLASM METASTASIS; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS;

EID: 70449419922     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000566     Document Type: Article

References (40)

1. CDC Lung Cancer: Statistics http://www.cdc.gov/cancer/lung/statistics/ Accessed 3/25/09).
2. Hart JA: Mesothelioma (Malignant); http://www.nlm.nih.gov/medlineplus/ ency/article/000115.htm, 2004.
3. Antman KH: Clinical presentation and natural history of benign and malignant mesothelioma. Semin Oncol 8: 313-320, 1981.
4. Fidler IJ: Molecular biology of cancer: invasion and metastasis. In: Cancer: Principles and Practice of Oncology. 5th edition. De Vita VT, Hellman S and Rosenberg SA (eds). Lippincott-Raven, Philadelphia, PA, pp135-152, 1997.
5. Liotta LA, Tryggvason K, Garbisa A, Hart I, Foltz CM and Shafie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67-68, 1980.
6. Stetler-Stevenson WG: The role of matrix metalloproteinases in tumor invasion, metastasis and angiogenesis. Surg Oncol Clin N Am 10: 383-392, 2001.
7. Cottam DW, Rennie IG, Woods K, Parsons MA, Bunning RA and Rees RC: Gelatinolytic metalloproteinase secretion patterns in ocular melanoma. Invest Ophthalmol Vis Sci 32: 1923-1927, 1992.
8. Fishman DA, Bafetti L, Banionis S, Kearns AS, Chilukuri K and Stack MS: Production of extracellular matrix degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells. Cancer 80: 1457-1463, 1997.
9. Garzetti G, Ciavattini A, Lucarini G, Goteri G, De Nicolis M, Garbisa S, Masiero L, Romanini C and Graziella B: Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarian serous cytstadenocarcinomas: clinical and prognostic implications. Anticancer Res 15: 2799-2804, 1995.
10. Gohji K, Fujomoto N, Hara I, Fujii A, Gotoh A, Okada H, Arakawa S, Kitazawa S, Miyake H, Kamidono S and Nakijima M: Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension. Int J Cancer 79: 96-101, 1998.
11. Hirano H, Tsugu M, Kizaki T, Sashikata T, Yoshi Y, Okada Y and Mori H: Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinase, collagens and ki67 antigen in pleural malignant mesothelioma: an immunohistochemical and electron microscopic study. Med Electron Microsc 35: 16-23, 2002.
12. Edwards JC, McLaren J, Jones JL, Walker DA and O'Byrne KJ: Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura. Br J Cancer 88: 1553-1559, 2003.
13. Schültz A, Schneidenbach D, Aust G, Tannpfel A, Steinert M and Wittekind C: Differential expression and activity status of MMP-1, MMP-2 and MMP-9 in tumor and stromal cells of squamous cell carcinomas of the lung. Tumor Biol 23: 179-184, 2002.
14. Takashi M, Kazumitsu O, Kazuo K, Yoshio N, Fuji N, Mamou K, Motohiko F, Nanao N and Yukiyasy S: Analysis of circulating plasma matrix metalloproteinases (MMP) and tissue inhibitors of MMP in lung cancer patients. J Nihon Univ Med Assoc 59: 97-102, 2000.
15. Stetler-Stevenson WG: Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 9: 289-303, 1990.
16. Bérubé M, Deschambeault A, Boucher M, Germain L, Petitclerc E and Guérin SL: MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment. Mol Vis 11: 1101-1111, 2005.
17. Sato T, Sakai T, Noguchi Y, Takta M, Hirakawa S and Ito A: Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Gynecol Oncol 92: 47-56, 2004.
18. Di Nezza LA, Misajon A, Zhang J, Jobling T, Quinn MA, Ostör AG, Nie G, Lopata A and Salamonsen LA: Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Cancer 94: 1466-1475, 2002.
19. Liotta LA and Kohn EC: The microenvironment of the tumor-host interface. Nature 411: 375-379, 2001.
20. Pyke C, Kristensen P, Ralfkiaer E, Gröndahl-Hansen J, Eriksen J, Blasi F and Danø K: Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Pathol 138: 1059-1067, 1991.
21. Harvey P, Clark IM, Jourand MC, Warn RM and Edwards DR: Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases. Br J Cancer 83: 1147-1153, 2000.
22. Liu Z, Ivanoff A, Klominek J: Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines. Int J Cancer 91: 638-643, 2001.
23. Vincenti MP, White LA, Schroen DJ, et al: Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription and mRNA stability. Crit Rev Eukaryot Gene Expr 6: 391-411, 1996.
24. Ray JM and Stetler-Stevenson WG: The role of matrix metalloproteinase and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 7: 2062-2072, 1994.
25. Apodaca G, Rutka JT, Bouhana K, Berens ME, Giblin JR, Rosenblum ML, McKerrow JH and Banda MJ: Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res 50: 2322-2329, 1990.
26. Richardson MA, Sanders T, Palmer JL, Greisinger A and Singletary SE: Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18: 2505-2514, 2000.
27. Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A and Rath M: Inhibition of pulmonary metastasis of melanoma B16FO cells in C57BL/6 mice by a nutrient mixture consisting of ascorbic acid, lysine, proline, arginine, and green tea extract. Exp Lung Res 32: 517-530, 2006.
28. Roomi MW, Kalinovsky T, Roomi NW, Ivanov V, Rath M and Niedzwiecki A: Suppression of growth and hepatic metastasis of murine B16FO melanoma cells by a novel nutrient mixture. Oncol Rep 20: 809-817, 2008.
29. Rath M and Pauling L: Plasmin-induced proteolysis and the role of apoprotein(a), lysine and synthetic analogs. Orthomolecular Med 7: 17-23, 1992.
30. Sun Z, Chen YH, Wang P, Zhang J, Gurewich V, Zhang P and Liu JN: The blockage of high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation. Biochem Biophys Acta 1596: 182-192, 2002.
31. Valcic S, Timmermann BN, Alberts DS, Wachter GA, Krutzsch M, Wymer J and Guillen JM: Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anticancer Drugs 7: 461-468, 1996.
32. Mukhtar H and Ahmed N: Tea polyphenols: prevention of cancer and optimizing health. AM J Clin Nutr 71: S1698-S1702, 2000.
33. Yang GY, Liao J, Kim K, Yurtow EJ and Yang CS: Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 19: 611-616, 1998.
34. Taniguchi S, Fujiki H, Kobayashi H, Go H, Miyado K, Sadano H and Shimikawa R: Effect of (-) epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines. Cancer Lett 65: 51-54, 1992.
35. Hare Y: Green Tea: Health Benefits and Applications. Marcel Dekker, Basel, New York, 2001.
36. Kawakami S, Kageyama Y, Fujii Y, Kihara K and Oshima H: Inhibitory effects of N-acetylcysteine on invasion and MMP-9 production of T24 human bladder cancer cells. Anticancer Res 21: 213-219, 2001.
37. Morini M, Cai T, Aluigi MG, Noonan DM, Masiello L, De Floro S, D'Agostinin F, Albini A and Fassima G: The role of the thiol N-acetyl cysteine in the prevention of tumor invasion and angiogenesis. Int J Biol Markers 14: 268-271, 1999.
38. Yoon SO, Kim MM and Chung AS: Inhibitory effects of selenite on invasion of HT 1080 tumor cells. J Biol Chem 276: 20085-20092, 2001.
39. Maramag C, Menon M, Balaji KC, Reddy PG and Laxmanan S: Effect of vitamin C on prostate cancer cells in vitro: effect on cell number, viability and DNA synthesis. Prostate 32: 188-195, 1997.
40. Cooke JP and Dzau VJ: Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 48: 489-509, 1997.